Literature DB >> 17084555

A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation.

Nam Kyu Kim1, Seung Hyuk Baik, Byung Soh Min, Hong Ryull Pyo, Yun Jung Choi, Hogeun Kim, Jinsil Seong, Ki Chang Keum, Sun Young Rha, Hyun Cheol Chung.   

Abstract

PURPOSE: To compare tumor volume reduction rate, histopathologic downstaging, and tumor regression grade (TRG) among tumor responses in rectal cancer after preoperative chemoradiotherapy (CRT). PATIENTS AND METHODS: Between 2002 and 2004, 30 patients with locally advanced rectal cancer underwent preoperative CRT, followed by surgical resection. Magnetic resonance volumetry was performed before and after CRT. Histopathologic tumor staging and tumor regression were reviewed. We compared pre- and post-CRT tumor volume and percent of volume reduction, according to histopathologic downstaging and TRG.
RESULTS: The tumor volume reduction rates ranged from 14.6% to 100%. Mean pre- and post-CRT tumor volumes were significantly smaller in patients who showed T downstaging than in those who did not (p = 0.040, 0.014). The mean tumor volume reduction was 66.4% vs. 55.2% (p = 0.361). However, the mean pre- and post-CRT tumor volume and mean tumor volume reduction rate between patients who showed N downstaging and those who did not were not statistically different (p = 0.176, 0.767, and 0.899). With respect to TRG, the mean pre- and post-CRT tumor volumes were not statistically significant (p = 0.108, 0.708, and 0.120).
CONCLUSION: Tumor volume reduction rate does not correlate with histopathologic downstaging and TRG. It might be hazardous to evaluate tumor response with respect to volume reduction and to select the surgical method on this basis.

Entities:  

Mesh:

Year:  2006        PMID: 17084555     DOI: 10.1016/j.ijrobp.2006.08.020

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Invited commentary on "Yun HR, Kim HC, Kim SH et al. (2010) Cytokeratin staining for complete remission in rectal cancer after chemoradiation. Int J Colorect Dis.

Authors:  Paul Hermanek
Journal:  Int J Colorectal Dis       Date:  2010-06-09       Impact factor: 2.571

2.  Endoscopic evaluation of clinical response after preoperative chemoradiotherapy for lower rectal cancer: the significance of endoscopic complete response.

Authors:  Atsushi Ogura; Akiko Chino; Tsuyoshi Konishi; Takashi Akiyoshi; Teruhito Kishihara; Yoshiro Tamegai; Masashi Ueno; Masahiro Igarashi
Journal:  Int J Colorectal Dis       Date:  2015-01-09       Impact factor: 2.571

3.  High-dose-rate intraluminal brachytherapy during preoperative chemoradiation for locally advanced rectal cancers.

Authors:  Mutahir Ali Tunio; Mansoor Rafi; Altaf Hashmi; Rehan Mohsin; Abdul Qayyum; Mujahid Hasan; Amjad Sattar; Muhammad Mubarak
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

4.  Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI.

Authors:  Ken Herrmann; Ralph A Bundschuh; Robert Rosenberg; Stefan Schmidt; Christine Praus; Michael Souvatzoglou; Karen Becker; Tibor Schuster; Markus Essler; Hinrich A Wieder; Helmut Friess; Sibylle I Ziegler; Markus Schwaiger; Bernd J Krause
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

5.  Neo-adjuvant chemo-radiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience.

Authors:  Antonella Richetti; Antonella Fogliata; Alessandro Clivio; Giorgia Nicolini; Gianfranco Pesce; Emanuela Salati; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2010-02-19       Impact factor: 3.481

6.  Factors associated with local recurrence after neoadjuvant chemoradiation with total mesorectal excision for rectal cancer.

Authors:  Nam-Kyu Kim; Young-Wan Kim; Byung-Soh Min; Kang-Young Lee; Seung-Kook Sohn; Chang-Hwan Cho
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

7.  Abdominoperineal excision following preoperative radiotherapy for rectal cancer: unfavorable prognosis even with negative circumferential resection margin.

Authors:  Lin Wang; Guo-Li Gu; Zhong-Wu Li; Yi-Fan Peng; Jin Gu
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

8.  Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy.

Authors:  Hong Il Ha; Ah Young Kim; Chang Sik Yu; Seong Ho Park; Hyun Kwon Ha
Journal:  Eur Radiol       Date:  2013-06-28       Impact factor: 5.315

9.  Assessment of response to chemoradiation therapy in rectal cancer using MR volumetry based on diffusion-weighted data sets: a preliminary report.

Authors:  S F Carbone; L Pirtoli; V Ricci; D Venezia; T Carfagno; S Lazzi; V Mourmouras; B Lorenzi; L Volterrani
Journal:  Radiol Med       Date:  2012-05-14       Impact factor: 3.469

10.  Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone: Results from a Prospective Trial.

Authors:  Jian Xiao; Zerong Cai; Wenyun Li; Zuli Yang; Jiaying Gong; Yan Huang; Yanhong Deng; Xiaojian Wu; Lei Wang; Junsheng Peng; Donglin Ren; Ping Lan; Jianping Wang
Journal:  J Cancer       Date:  2015-05-26       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.